Your trusted destination for CME, CPD & Medical Education across the Middle East.
King Faisal Specialist Hospital and Research Centre, Saudi Arabia
Dr. Badr Al-Bawardy is an internationally distinguished consultant gastroenterologist, inflammatory bowel disease (IBD) specialist, and clinical investigator who has dedicated over fifteen years to advancing therapeutic luminal endoscopy,complex IBD management, and gastroenterology research across North America and the Middle East. He earned his primary medical degree (MD) with high academic honors, followed by rigorous postgraduate residency training in internal medicine and specialized fellowship training in gastroenterology and hepatology. Demonstrating an unyielding commitment to clinical subspecialty excellence, he completed advanced subspecialty fellowship training dedicated exclusively to inflammatory bowel disease at world-renowned academic medical centers in the United States.
Holding senior consultant appointments and academic directorships across premier tertiary institutions—notably as a Consultant Gastroenterologist at King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Riyadh and Adjunct Assistant Professor of Medicine at Yale School of Medicine—Dr. Al-Bawardy oversees high-volume IBD centers, specialized endoscopy suites, and advanced clinical research programs. His extensive clinical and procedural scope encompasses diagnostic and therapeutic esophagogastroduodenoscopy (EGD), colonoscopy, endoscopic management of IBD complications (including stricture dilation and fistula assessment), biological therapy optimization,and early gastrointestinal neoplasia surveillance. Throughout his career, he has been a driving force behind establishing multidisciplinary IBD care models and standardizing treat-to-target strategies for complex luminal diseases.
Beyond his direct clinical practice, Dr. Al-Bawardy is a prolific research scholar, author, and active member of prestigious regional and international gastroenterology organizations, including the American Gastroenterological Association (AGA) and the Crohn's & Colitis Foundation. He has authored and co-authored numerous peer-reviewed scientific articles,systematic reviews, and clinical trials examining mucosal healing markers, health-economic impacts of GI diseases, and novel pharmacological therapeutics in IBD. Collaborating closely with federal health authorities and global research consortia, he actively contributes to formulating evidence-based diagnostic guidelines and epidemiology frameworks designed to reduce the disease burden of chronic intestinal disorders.
As a dedicated medical educator and frequent speaker at international congresses, Dr. Al-Bawardy regularly conducts continuous professional development symposia, clinical case workshops, and mentorship programs for resident physicians, gastroenterology fellows, and clinical nurses. At Saudi Endoscopy Days 2026, his expert lectures, session chairmanships, and interactive round-table case reviews provide delegates with cutting-edge clinical evidence, practical endoscopic frameworks, and actionable strategies to advance patient outcomes and procedural safety globally.

Saudi Gastroenterology Association (SGA)
Saudi Gastroenterology Association (SGA)